ADXN - Addex Therapeutics Ltd. Profit before interest, taxes and amortization
Addex Therapeutics (ADXN) combines the fine-tuning of brain receptors to combat dyskinesia with the development of advanced treatments for dystonia. Monitoring EBITDA_Co allows these scientific achievements to be weighed against financial stability, where the current mark stands at 0.00. High confidence from the global neurobiology community and partnerships with pharma behemoths confirm the company's status as a reliable innovator in Parkinson's disease therapy.
Addex Therapeutics Ltd (ADXN) - metric breakdowns and financial figures
- share price and expert price forecast:
- market capitalization statistics:
- book capitalization data:
- company total debt and liquidity indicators:
Aggregate Debt to Capital Addex Therapeutics|ADXN - Long-Term Debt to Capital|Ratio of Short-Term Indebtedness to Capital Addex Therapeutics Ltd.|ADXN - Company Aggregate Debts|Debts to Book Value Addex Therapeutics|ADXN - Company Long-Term Debt|Company Short-Term Loans and Borrowings Addex Therapeutics|Quick Ratio addextherapeutics.com
- earnings and valuation multiples indicators:
ADXN - Company Net Income|Forward Earnings Addex Therapeutics|ADXN - P/E Multiple|Projected Price to Earnings Ratio addextherapeutics.com|ADXN - Price/Earnings to Growth Multiple|EV/EBITDA Multiple Addex Therapeutics|ADXN - Operating profit before deduction of amortization|Earnings per share for the last four quarters Addex Therapeutics|ADXN - Net earnings per share (EPS TTM)|Year-over-year net earnings per share change for the last twelve months addextherapeutics.com|ADXN - Earnings growth in current year|Expected earnings per share growth for next year Addex Therapeutics
Summary company analytics:Addex Therapeutics
Cash flow analysis minimizes risks, confirming the ability of Addex Therapeutics (ADXN) to monetize CNS modulator patents through stable demand for chronic diseases. The current value of 0.00 reflects daily operating profit before taxes and interest, while EBITDA dynamics allow for an assessment of capital stability and the business's real liquidity during periods of market volatility.
Competitors of Addex Therapeutics (ADXN)
BIIB: Operating profit before amortization|Neurocrine Biosciences - Operating profit EBITDA|Profit before interest, taxes and amortization regencellbioscience.com|AXSM (Axsome Therapeutics, Inc.) - Operating profit before deduction of amortization|Operating profit before amortization ACAD|Operating profit before deduction of amortization XENE|VKTX: Income before deduction of interest, taxes and amortization|Operating profit before deduction of amortization SUPN (Supernus Pharmaceuticals)|Company profit before taxes, interest and amortization CPRX|Operating profit EBITDA DNLI (Denali Therapeutics Inc.)|Income before deduction of interest, taxes and amortization HRMY|Biohaven Pharmaceutical - Operating profit EBITDA|Profit before interest, taxes and amortization Amylyx Corp|Trevi Therapeutics (TRVI) - Profit before payment of interest, taxes and amortization|praxismedicines.com - Income before deduction of interest, taxes and amortization|AVXL (Anavex Life Sciences Corp.) - Operating profit EBITDA|Operating profit EBITDA CeriBell Inc|Profit before payment of interest, taxes and amortization Prothena Corp (PRTA)|ALEC: Profit before deduction of interest, taxes, depreciation and amortization|Operating profit EBITDA ANNX (Annexon, Inc.)|Omeros Corp (OMER) - Profit before interest, taxes and amortization|NGNE: Operating profit before deduction of amortization|ACIU - Operating profit EBITDA|VYGR (Voyager Pharma) - Operating profit before deduction of amortization|NMRA: Company profit before taxes, interest and amortization|SCLX (Scilex Holding Company) - Operating profit EBITDA|tevogen.com (TVGN) - Operating income before deduction of amortization|Operating profit EBITDA ACOG|Operating profit before deduction of amortization Cognition Therapeutics Inc. CGTX|Profit before payment of interest, taxes and amortization Inhibikase IKT|Operating income before deduction of amortization Cassava Pharma (SAVA)|Assertio Therapeutics - Operating profit EBITDA|COYA - Operating profit EBITDA|VTGN: Operating profit EBITDA|Operating profit before amortization OVID|Operating profit before deduction of amortization ABOS|Operating profit before amortization CRVO (CervoMed Corporation)|Profit before payment of interest, taxes and amortization Alterity Therapeutics (ATHE)|clene.com - Operating profit before amortization|Profit before payment of interest, taxes and amortization PepGen PEPG|JUNS: Operating profit before amortization|Relmada - Operating profit EBITDA|Profit before interest, taxes and amortization Annovis Bio Corporation|GRCE (gracetx.com) - Operating profit before deduction of amortization|fireflyneuro.com (AIFF) - Operating profit EBITDA|Profit before payment of interest, taxes and amortization ANEW Medical|NRSN: Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Reviva Pharmaceuticals Holdings (RVPH)|MTVA - Profit before interest, taxes and amortization|Operating profit EBITDA NRXS (NeurAxis, Inc.)|Operating profit EBITDA Helius Medical Technologies, Inc. HSDT|Passage Bio Corp - Operating profit EBITDA|NEUP (Neuphoria Therapeutics Inc.) - Operating profit before amortization|NERV: Operating profit EBITDA|Operating profit before amortization ATHA|ALZN (Alzamend Neuro Inc.) - Operating profit EBITDA|Profit before interest, taxes and amortization Cyclerion CYCN|Operating profit before deduction of amortization PTIX (Protagenic Therapeutics)|pasitheaclinics.com - Operating profit before amortization|Cortigent - Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization ATXI|BCLI: Operating profit before deduction of amortization|caratherapeutics.com - Company profit before taxes, interest and amortization|CHRO: Operating profit EBITDA|Eliem Therapeutics Inc. - Income before deduction of interest, taxes and amortization|ITCI (Intra-Cellular Therapies Inc.) - Operating profit EBITDA|Profit before interest, taxes and amortization Longboard LBPH|Profit before payment of interest, taxes and amortization Marinus Pharmaceuticals (MRNS)|NKGN (nkgenbiotech.com) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA NRBO (NeuroBo Pharmaceuticals, Inc.)|Operating profit EBITDA Sage Therapeutics Inc. SAGE|SNPX - Profit before payment of interest, taxes and amortization|Profit before deduction of interest, taxes, depreciation and amortization TRVN|VIGL: Operating profit EBITDA|Profit before interest, taxes and amortization anewmeds.com (WENA)|Operating profit before deduction of amortization CERE
